Cargando…
Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair
DNA damage is a double-edged sword for cancer cells. On the one hand, DNA damage–induced genomic instability contributes to cancer development; on the other hand, accumulating damage compromises proliferation and survival of cancer cells. Understanding the key regulators of DNA damage repair machine...
Autores principales: | Tang, Jingyi, Casey, Patrick J, Wang, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500237/ https://www.ncbi.nlm.nih.gov/pubmed/34610973 http://dx.doi.org/10.26508/lsa.202101144 |
Ejemplares similares
-
Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt)
por: Baron, Rudi A, et al.
Publicado: (2004) -
Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms
por: Lau, H Y, et al.
Publicado: (2017) -
Isoprenylcysteine Carboxylmethyltransferase-Based
Therapy for Hutchinson–Gilford Progeria Syndrome
por: Marcos-Ramiro, Beatriz, et al.
Publicado: (2021) -
Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
por: Chai, Tin Fan, et al.
Publicado: (2020) -
Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT)
por: Teng, Xiaodan, et al.
Publicado: (2021)